PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1779952
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1779952
The global molecular quality controls market is set for steady growth, with a market size of USD 220 million in 2024. The market is projected to reach USD 388 million by 2032, advancing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032. This growth is driven by the increasing demand for accurate and reliable diagnostic testing, particularly in molecular diagnostics, which are essential for disease detection and personalized treatment.
As healthcare continues to evolve with advancements in molecular biology and genetic research, the need for effective quality control in molecular testing laboratories is becoming more critical. Molecular quality controls are used to assess the performance of diagnostic tests, ensuring the accuracy and consistency of results. The market is also benefiting from the growing adoption of molecular diagnostic technologies in areas like infectious disease testing, oncology, and genetic testing.
Key Insights
The global molecular quality controls market is expected to grow at a CAGR of 7.5% from 2025 to 2032, reaching a projected value of USD 388 million by 2032, up from USD 220 million in 2024.
The increasing use of molecular diagnostic tests, which are vital for detecting genetic, infectious, and oncological diseases, is driving the demand for molecular quality controls.
As the healthcare industry focuses more on precision medicine, the need for accurate molecular diagnostic testing is growing, pushing for enhanced quality control to ensure reliable results in clinical laboratories.
The adoption of advanced molecular diagnostic techniques, including PCR (polymerase chain reaction), next-generation sequencing (NGS), and CRISPR-based diagnostics, is a significant factor contributing to the rise of the molecular quality controls market.
Molecular quality controls are essential in maintaining laboratory accreditation and ensuring that diagnostic tests consistently meet regulatory and performance standards.
The market is segmented by product type, including external controls, internal controls, and others, with external controls expected to hold the largest market share due to their widespread use in laboratories for ensuring test accuracy.
The growing demand for molecular quality controls is driven by the increasing number of diagnostic tests performed for infectious diseases, cancer, genetic disorders, and other conditions that require precise and reliable results.
The oncology sector, in particular, is expected to drive significant growth in the market as molecular diagnostics become more integrated into cancer detection, prognostication, and treatment decisions.
Regulatory bodies and guidelines from organizations like the FDA (Food and Drug Administration) and ISO (International Organization for Standardization) are encouraging the use of molecular quality controls to maintain high standards in diagnostic testing.
The competitive landscape features both established players in the molecular diagnostics industry and emerging companies offering specialized molecular quality control products. These companies are focusing on developing innovative solutions that enhance accuracy, sensitivity, and cost-effectiveness.
The market also benefits from the increasing number of accredited testing laboratories and the rising trend of point-of-care molecular diagnostic testing, which is contributing to the need for reliable quality control solutions.